CD274 and neoplasm: Overexpression of PD-L1 by tumor cells or immune cells in the tumor microenvironment is a commonly used biomarker, but some patients respond to treatment even with negative or low PD-L1 expression and a standard method of detection and measurement of PD-L1 status is still being established.